Anbio Biotechnology's Hype And Hard Approvals Suggest A Stretched Valuation
Source: SeekingAlpha
2025-10-10 12:47:30 ET
...
Read the full article on Seeking Alpha
For further details see:
Anbio Biotechnology's Hype And Hard Approvals Suggest A Stretched Valuation
Anbio Biotechnology
NASDAQ: NNNN
NNNN Trading
7.83% G/L:
$23.01 Last:
2,036 Volume:
$22.79 Open:
NNNN Latest News
March 17, 2026 04:30:00 pm
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
August 08, 2025 09:05:14 pm
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
May 15, 2025 01:05:47 am
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
March 07, 2025 09:10:00 am
Investorideas.com adds New IPOs in Biotech, Technology, Homebuilder, Aerospace, Sports
